These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 11332424)

  • 21. Treatment of stage II cutaneous T-cell lymphoma with interferon alfa-2a and extracorporeal photochemotherapy: a prospective controlled trial.
    Wollina U; Looks A; Meyer J; Knopf B; Koch HJ; Liebold K; Hipler UC
    J Am Acad Dermatol; 2001 Feb; 44(2):253-60. PubMed ID: 11174383
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Photochemotherapy (PUVA) in the tumour stage of mycosis fungoides: a report from the Scandinavian Mycosis Fungoides Study Group.
    Molin L; Thomsen K; Volden G; Groth O
    Acta Derm Venereol; 1981; 61(1):52-4. PubMed ID: 6164215
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of childhood mycosis fungoides with topical PUVA.
    Pabsch H; Rütten A; Von Stemm A; Meigel W; Sander CA; Schaller J
    J Am Acad Dermatol; 2002 Oct; 47(4):557-61. PubMed ID: 12271301
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Therapeutic Update: Update on Cutaneous and Systemic Therapy for Primary Cutaneous T Cell Lymphoma, Mycosis Fungoides.
    Lo Sicco K; Latkowski JA
    J Drugs Dermatol; 2015 Dec; 14(12):1381-3. PubMed ID: 26659928
    [No Abstract]   [Full Text] [Related]  

  • 25. State of the art therapy of mycosis fungoides and Sézary syndrome.
    Kemme DJ; Bunn PA
    Oncology (Williston Park); 1992 Feb; 6(2):31-42; discussion 44, 47-8. PubMed ID: 1532501
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bexarotene salvage therapy in a patient with refractory erythrodermic mycosis fungoides after failure on interferon/PUVA and methotrexate.
    Dalle S; Thomas L
    Dermatol Clin; 2008 Jan; 26 Suppl 1():39-41. PubMed ID: 18405186
    [No Abstract]   [Full Text] [Related]  

  • 27. Treatment of mycosis fungoides with imiquimod 5% cream.
    Ariffin N; Khorshid M
    Clin Exp Dermatol; 2006 Nov; 31(6):822-3. PubMed ID: 17040269
    [No Abstract]   [Full Text] [Related]  

  • 28. Electrochemotherapy of Mycosis fungoides by interferon-alpha.
    Peycheva E; Daskalov I; Tsoneva I
    Bioelectrochemistry; 2007 May; 70(2):283-6. PubMed ID: 17150416
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Current systemic therapeutic options for advanced mycosis fungoides and Sézary syndrome.
    Janiga J; Kentley J; Nabhan C; Abdulla F
    Leuk Lymphoma; 2018 Mar; 59(3):562-577. PubMed ID: 29308723
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interferon-α2b-induced STAT3 suppression in myeloid-derived suppressor cells in mycosis fungoides.
    Geskin LJ; Akilov OE; Schowalter MK; Falo LD
    Cancer Immunol Immunother; 2018 Jul; 67(7):1177-1178. PubMed ID: 29619509
    [No Abstract]   [Full Text] [Related]  

  • 31. Granulomatous slack skin or granulomatous mycosis fungoides -- a case report. Complete response to percutaneous radiation and interferon alpha.
    Wollina U; Graefe T; Füller J
    J Cancer Res Clin Oncol; 2002 Jan; 128(1):50-4. PubMed ID: 11862472
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Remission in skin infiltrate of a patient with mycosis fungoides treated with cyclosporine.
    Maddox AM; Kahan BD; Tucker S; Kerman R; Jordan RE
    J Am Acad Dermatol; 1985 May; 12(5 Pt 2):952-6. PubMed ID: 3158679
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combination therapy of cutaneous T cell lymphoma with interferon alpha-2a and photochemotherapy.
    Stadler R; Otte HG
    Recent Results Cancer Res; 1995; 139():391-401. PubMed ID: 7597306
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effective treatment of a case of refractory mycosis fungoides with imatinib.
    Oka S; Yokote T; Hara S; Akioka T; Kobayashi K; Hirata Y; Yamano T; Endo Y; Tsuji M; Hanafusa T
    Br J Haematol; 2006 May; 133(4):353. PubMed ID: 16643439
    [No Abstract]   [Full Text] [Related]  

  • 35. Interferon-alpha is effective for CD4(+), CCR4(-) mycosis fungoides.
    Fujimura T; Okuyama R; Watabe A; Hashimoto A; Tagami H; Aiba S
    Int J Dermatol; 2007 Apr; 46(4):435-8. PubMed ID: 17442093
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Scandinavian mycosis fungoides trial.
    Thomsen K
    Cancer Treat Rep; 1979 Apr; 63(4):709-11. PubMed ID: 445520
    [No Abstract]   [Full Text] [Related]  

  • 37. Unilesional mycosis fungoides successfully treated with imiquimod.
    Ardigò M; Cota C; Berardesca E
    Eur J Dermatol; 2006; 16(4):446. PubMed ID: 16935811
    [No Abstract]   [Full Text] [Related]  

  • 38. Phase II trial of fludarabine phosphate and interferon alfa-2a in advanced mycosis fungoides/Sézary syndrome.
    Foss FM; Ihde DC; Linnoila IR; Fischmann AB; Schechter GP; Cotelingam JD; Steinberg SM; Ghosh BC; Stocker JL; Bastian A
    J Clin Oncol; 1994 Oct; 12(10):2051-9. PubMed ID: 7931473
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Peginterferon alfa-2b for mycosis fungoides.
    Yanagi T; Shimizu T; Ujiie H; Ito M; Abe R; Tsuji-Abe Y; Hige S; Shimizu H
    Arch Dermatol; 2006 May; 142(5):649-51. PubMed ID: 16702510
    [No Abstract]   [Full Text] [Related]  

  • 40. Psoralen plus ultraviolet A +/- interferon-alpha treatment resistance in mycosis fungoides: the role of tumour microenvironment, nuclear transcription factor-kappaB and T-cell receptor pathways.
    Wozniak MB; Tracey L; Ortiz-Romero PL; Montes S; Alvarez M; Fraga J; Fernández Herrera J; Vidal S; Rodriguez-Peralto JL; Piris MA; Villuendas Deceased R
    Br J Dermatol; 2009 Jan; 160(1):92-102. PubMed ID: 18945306
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.